Seer (SEER) Competitors $2.11 +0.06 (+2.93%) As of 03:26 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SEER vs. CTKB, LAB, SENS, FEIM, QSI, MASS, QTRX, KEQU, OWLT, and RPIDShould you be buying Seer stock or one of its competitors? The main competitors of Seer include Cytek Biosciences (CTKB), Standard BioTools (LAB), Senseonics (SENS), Frequency Electronics (FEIM), Quantum-Si (QSI), 908 Devices (MASS), Quanterix (QTRX), Kewaunee Scientific (KEQU), Owlet (OWLT), and Rapid Micro Biosystems (RPID). These companies are all part of the "measuring and control equipment" industry. Seer vs. Its Competitors Cytek Biosciences Standard BioTools Senseonics Frequency Electronics Quantum-Si 908 Devices Quanterix Kewaunee Scientific Owlet Rapid Micro Biosystems Cytek Biosciences (NASDAQ:CTKB) and Seer (NASDAQ:SEER) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, media sentiment, risk, profitability and institutional ownership. Do analysts prefer CTKB or SEER? Cytek Biosciences currently has a consensus price target of $5.60, indicating a potential upside of 34.13%. Given Cytek Biosciences' stronger consensus rating and higher probable upside, equities research analysts clearly believe Cytek Biosciences is more favorable than Seer.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cytek Biosciences 1 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.20Seer 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Is CTKB or SEER more profitable? Cytek Biosciences has a net margin of -3.27% compared to Seer's net margin of -506.15%. Cytek Biosciences' return on equity of -1.66% beat Seer's return on equity.Company Net Margins Return on Equity Return on Assets Cytek Biosciences-3.27% -1.66% -1.30% Seer -506.15%-25.10%-22.48% Which has more risk and volatility, CTKB or SEER? Cytek Biosciences has a beta of 1.34, indicating that its stock price is 34% more volatile than the S&P 500. Comparatively, Seer has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Do institutionals & insiders hold more shares of CTKB or SEER? 69.5% of Cytek Biosciences shares are owned by institutional investors. Comparatively, 75.2% of Seer shares are owned by institutional investors. 10.3% of Cytek Biosciences shares are owned by company insiders. Comparatively, 11.3% of Seer shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has higher valuation & earnings, CTKB or SEER? Cytek Biosciences has higher revenue and earnings than Seer. Cytek Biosciences is trading at a lower price-to-earnings ratio than Seer, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCytek Biosciences$200.45M2.65-$6.02M-$0.05-83.50Seer$14.17M8.39-$86.60M-$1.39-1.52 Does the media prefer CTKB or SEER? In the previous week, Seer had 6 more articles in the media than Cytek Biosciences. MarketBeat recorded 7 mentions for Seer and 1 mentions for Cytek Biosciences. Cytek Biosciences' average media sentiment score of 1.22 beat Seer's score of -0.21 indicating that Cytek Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cytek Biosciences 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Seer 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryCytek Biosciences beats Seer on 10 of the 16 factors compared between the two stocks. Get Seer News Delivered to You Automatically Sign up to receive the latest news and ratings for SEER and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SEER and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SEER vs. The Competition Export to ExcelMetricSeerMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$118.88M$3.09B$5.82B$9.75BDividend YieldN/A2.23%3.84%4.09%P/E Ratio-1.5221.0131.1425.96Price / Sales8.39396.98475.48122.90Price / CashN/A43.0937.1558.38Price / Book0.418.069.116.38Net Income-$86.60M-$54.72M$3.26B$265.56M7 Day Performance1.93%2.30%1.94%1.81%1 Month Performance-1.86%7.21%4.91%1.14%1 Year Performance30.25%12.85%31.21%20.98% Seer Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SEERSeer0.5401 of 5 stars$2.11+2.9%N/A+24.2%$118.88M$14.17M-1.52160CTKBCytek Biosciences3.5248 of 5 stars$3.79-6.0%$5.60+47.8%-25.5%$512.71M$200.45M-75.80500Positive NewsLABStandard BioTools2.5558 of 5 stars$1.28-2.3%$2.50+96.1%-38.1%$495.67M$174.43M-3.64620Gap UpSENSSenseonics2.4156 of 5 stars$0.47-5.9%$1.55+232.3%+6.2%$305.13M$25.47M-3.5990News CoveragePositive NewsFEIMFrequency Electronics1.3238 of 5 stars$29.17-1.2%N/A+110.5%$287.27M$69.81M11.81200QSIQuantum-Si2.2846 of 5 stars$1.20-5.5%$3.48+189.6%+9.9%$233.04M$3.06M-1.76150MASS908 Devices3.4662 of 5 stars$6.43+1.6%$8.00+24.4%+42.7%$227M$59.63M-11.9160QTRXQuanterix2.4013 of 5 stars$4.58-3.6%$11.75+156.6%-63.2%$220.71M$137.42M-2.52460Positive NewsKEQUKewaunee Scientific2.2399 of 5 stars$54.97+3.7%N/A+7.7%$156.19M$240.47M14.351,239Positive NewsShort Interest ↓OWLTOwlet3.3236 of 5 stars$8.91-4.2%$10.25+15.1%+65.0%$153.68M$78.10M-2.54106Gap UpRPIDRapid Micro Biosystems3.9515 of 5 stars$3.26-4.1%$8.00+145.4%+219.1%$149.03M$28.05M-3.17200Positive News Related Companies and Tools Related Companies Cytek Biosciences Alternatives Standard BioTools Alternatives Senseonics Alternatives Frequency Electronics Alternatives Quantum-Si Alternatives 908 Devices Alternatives Quanterix Alternatives Kewaunee Scientific Alternatives Owlet Alternatives Rapid Micro Biosystems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SEER) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersSilver’s Still Under $35… For Now.Silver is trading around $33—but insiders are betting on a $70 breakout by year’s end. With supply shrinkin...GoldenCrest Metals | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seer, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Seer With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.